AI加速生物活性原料创新，「未名拾光」获数千万元B+轮融资

Core Insights - "Weiming Shiguang" recently secured several tens of millions of RMB in B+ round financing, led by Huatai Jinse and Haibang Investment, aimed at enhancing AI technology platform development, expanding diverse applications of biomaterials, and accelerating global business layout [1] - The company has developed a closed-loop synthetic biology technology platform focusing on innovative biomaterials, utilizing AI to empower the platform comprehensively [1][3] - The company has established a business model that meets the needs of the beauty, medical device, and food industries, combining self-developed innovative raw material pipelines with a CRDMO model to collaborate with downstream brand manufacturers [1][6] Investment and Financing - The recent financing follows nearly 100 million RMB investment from L'Oréal and Nai's Group in May, indicating strong investor confidence and interest in the company's growth potential [1] - The funds will primarily be used for AI technology platform enhancement and global business expansion [1] Technology and Innovation - The company has established two types of cell factories—microbial and plant-based—to produce peptides and proteins, including collagen and fibronectin [2] - Utilizing plant callus technology, the company has induced callus from over 80 plant species, with three extracts approved as new cosmetic raw materials, representing 75% of the total approved by the regulatory authority [2] - AI has significantly improved research and development efficiency, reportedly increasing it by at least five times, with plans to allocate 50% of R&D spending towards AI development [4] Product Development and Market Strategy - The company employs a "reverse development" approach, focusing on the needs of downstream brand clients to provide raw material development services [6] - The emphasis is on developing differentiated "high-end" raw materials, particularly rare plant extracts that offer unique market value [6] - The company aims to expand its active ingredient business from beauty products to food and daily chemicals, with plans for international expansion [8] Collaboration and Client Network - The company has established a wide market channel and client network, collaborating with major brands like L'Oréal, Procter & Gamble, and Shanghai Jahwa for joint development [7] - The introduction of a novel "in vivo transdermal absorption Raman spectroscopy detection" technology has attracted numerous beauty and personal care brands, enhancing client relationships and laying the groundwork for CRDMO services [7]